Source: Plos Neglected Tropical Diseases. Unidades: IQ, FM, CEBIMAR
Subjects: DOENÇA DE CHAGAS, GENOMAS, ANTICORPOS, TRYPANOSOMA CRUZI
ABNT
CARNERO, Luis Antonio Rodriguez et al. Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display. Plos Neglected Tropical Diseases, v. 17, n. 1, p. 1-20 art. e0011019, 2023Tradução . . Disponível em: https://doi.org/10.1371/journal.pntd.0011019. Acesso em: 15 nov. 2024.APA
Carnero, L. A. R., Kuramoto, A., Oliveira, L. C. de, Monteiro, J. S., Setubal, J. C., Cunha Neto, E., et al. (2023). Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display. Plos Neglected Tropical Diseases, 17( 1), 1-20 art. e0011019. doi:10.1371/journal.pntd.0011019NLM
Carnero LAR, Kuramoto A, Oliveira LC de, Monteiro JS, Setubal JC, Cunha Neto E, Sabino EC, Giordano RJ. Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display [Internet]. Plos Neglected Tropical Diseases. 2023 ; 17( 1): 1-20 art. e0011019.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1371/journal.pntd.0011019Vancouver
Carnero LAR, Kuramoto A, Oliveira LC de, Monteiro JS, Setubal JC, Cunha Neto E, Sabino EC, Giordano RJ. Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display [Internet]. Plos Neglected Tropical Diseases. 2023 ; 17( 1): 1-20 art. e0011019.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1371/journal.pntd.0011019